author-photo

Julia Foster

Harvard University

27

Papers

373

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

PD-1 inhibition in advanced myeloproliferative neoplasms.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (9)
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (6)
Concurrent FLT3 Inhibitor and IDH Inhibitor Therapy in Patients with Acute Myeloid Leukemia (AML)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
A Phase 1 Trial of Regorafenib in Advanced Myeloid Malignancies

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

2019 Oncologist
Show All
- Source
- Cite
- Save
Citations (30)
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (20)